Michael I. Page

5.8k total citations · 1 hit paper
171 papers, 4.5k citations indexed

About

Michael I. Page is a scholar working on Organic Chemistry, Molecular Biology and Spectroscopy. According to data from OpenAlex, Michael I. Page has authored 171 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Organic Chemistry, 72 papers in Molecular Biology and 42 papers in Spectroscopy. Recurrent topics in Michael I. Page's work include Chemical Reaction Mechanisms (43 papers), Antibiotics Pharmacokinetics and Efficacy (37 papers) and Synthesis of β-Lactam Compounds (36 papers). Michael I. Page is often cited by papers focused on Chemical Reaction Mechanisms (43 papers), Antibiotics Pharmacokinetics and Efficacy (37 papers) and Synthesis of β-Lactam Compounds (36 papers). Michael I. Page collaborates with scholars based in United Kingdom, Belgium and United States. Michael I. Page's co-authors include William P. Jencks, Andrew P. Laws, Adriana Badarau, John H. Atherton, Matthew Stirling, A. John Blacker, Moreno Galleni, Andrew Williams, Nigel P. Gensmantel and Steven M. Allin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Chemical Society Reviews.

In The Last Decade

Michael I. Page

169 papers receiving 4.3k citations

Hit Papers

Entropic Contributions to... 1971 2026 1989 2007 1971 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Michael I. Page 2.2k 1.8k 841 591 560 171 4.5k
Manlio Palumbo 1.9k 0.9× 4.1k 2.2× 222 0.3× 461 0.8× 345 0.6× 236 6.2k
Grant K. Walkup 655 0.3× 1.9k 1.0× 1.0k 1.2× 617 1.0× 1.4k 2.4× 25 4.3k
Andrew G. Myers 7.8k 3.5× 3.1k 1.7× 296 0.4× 1.5k 2.5× 253 0.5× 191 10.0k
Jonathan R. Dimmock 2.6k 1.2× 1.7k 0.9× 281 0.3× 541 0.9× 123 0.2× 178 4.1k
Robert M. Adlington 3.6k 1.6× 1.9k 1.0× 284 0.3× 926 1.6× 150 0.3× 243 5.3k
David L. Tierney 469 0.2× 1.1k 0.6× 1.0k 1.2× 367 0.6× 170 0.3× 114 3.5k
D. H. R. BARTON 8.2k 3.7× 2.6k 1.4× 122 0.1× 599 1.0× 537 1.0× 303 10.6k
Manfred Kansy 2.3k 1.0× 2.6k 1.4× 81 0.1× 385 0.7× 991 1.8× 59 6.8k
Kenji Maeda 1.2k 0.5× 1.4k 0.7× 126 0.1× 520 0.9× 138 0.2× 113 3.1k
Martin E. Tanner 1.7k 0.8× 2.0k 1.1× 90 0.1× 333 0.6× 336 0.6× 95 3.8k

Countries citing papers authored by Michael I. Page

Since Specialization
Citations

This map shows the geographic impact of Michael I. Page's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael I. Page with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael I. Page more than expected).

Fields of papers citing papers by Michael I. Page

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael I. Page. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael I. Page. The network helps show where Michael I. Page may publish in the future.

Co-authorship network of co-authors of Michael I. Page

This figure shows the co-authorship network connecting the top 25 collaborators of Michael I. Page. A scholar is included among the top collaborators of Michael I. Page based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael I. Page. Michael I. Page is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Page, Michael I., et al.. (2017). Sphingosine and dihydrosphingosine as biomarkers for multiple sclerosis identified by metabolomic profiling using coupled UPLC-MS. Analytical Methods. 9(41). 5929–5934. 3 indexed citations
2.
Ji, Pengju, John H. Atherton, & Michael I. Page. (2012). Organic reactivity in liquid ammonia. Organic & Biomolecular Chemistry. 10(30). 5732–5732. 14 indexed citations
3.
Ward, Roberta J., Frédéric Lallemand, Philippe De Witte, et al.. (2011). Anti-inflammatory actions of a taurine analogue, ethane β-sultam, in phagocytic cells, in vivo and in vitro. Biochemical Pharmacology. 81(6). 743–751. 22 indexed citations
4.
Russell, Mark A., Andrew P. Laws, John H. Atherton, & Michael I. Page. (2008). The kinetics and mechanism of the acid-catalysed detritylation of nucleotides in non-aqueous solution. Organic & Biomolecular Chemistry. 7(1). 52–57. 11 indexed citations
5.
Ahmed, Naveed, et al.. (2007). Reactivity and selectivity in the inhibition of elastase by 3-oxo-β-sultams and in their hydrolysis. Organic & Biomolecular Chemistry. 5(24). 3993–3993. 18 indexed citations
6.
Ahmed, Naveed, et al.. (2007). The aminolysis of N-aroyl β-lactams occurs by a concerted mechanism. Organic & Biomolecular Chemistry. 5(3). 485–493. 11 indexed citations
7.
Hanusek, Jiří, Mark A. Russell, Andrew P. Laws, et al.. (2007). Mechanism of the sulfurisation of phosphines and phosphites using 3-amino-1,2,4-dithiazole-5-thione (xanthane hydride). Organic & Biomolecular Chemistry. 5(3). 478–484. 10 indexed citations
8.
Schofield, Christopher J., et al.. (2004). The inhibition of metallo-β-lactamase by thioxo-cephalosporin derivatives. Bioorganic & Medicinal Chemistry Letters. 14(7). 1737–1739. 17 indexed citations
9.
Page, Michael I., et al.. (2003). Novel mechanism of inhibiting β-Lactamases by sulfonylation using β-Sultams. Bioorganic & Medicinal Chemistry Letters. 13(24). 4489–4492. 19 indexed citations
10.
Page, Michael I.. (2002). Understanding metallo β-lactamases. University of Huddersfield Repository (University of Huddersfield). 17(3). 177–83. 3 indexed citations
11.
Wood, J. Matthew, et al.. (2002). Structure–reactivity relationships in the inactivation of elastase by β-sultams. Organic & Biomolecular Chemistry. 1(1). 67–80. 38 indexed citations
12.
Wood, J. Matthew, et al.. (2002). Hydrolysis of a sulfonamide by a novel elimination mechanism generated by carbanion formation in the leaving group. Chemical Communications. 772–773. 12 indexed citations
13.
Seny, Dominique de, Carine Bebrone, Gian María Rossolini, et al.. (2002). Mutational analysis of the two zinc-binding sites of the Bacillus cereus 569/H/9 metallo-β-lactamase. Biochemical Journal. 363(3). 687–687. 40 indexed citations
14.
Slater, Martin J., Andrew P. Laws, & Michael I. Page. (2001). The Relative Catalytic Efficiency of β-Lactamase Catalyzed Acyl and Phosphyl Transfer. Bioorganic Chemistry. 29(2). 77–95. 9 indexed citations
15.
Galleni, Moreno, et al.. (2001). Cysteinyl peptide Inhibitors of Bacillus cereus Zinc β-Lactamase. Bioorganic & Medicinal Chemistry. 9(2). 503–510. 47 indexed citations
16.
Breytenbach, Jaco C., et al.. (2000). Synthesis and antimicrobial activity of some isoindolin-1-ones derivatives. Bioorganic & Medicinal Chemistry Letters. 10(15). 1629–1631. 55 indexed citations
17.
Page, Michael I., et al.. (1999). Peptidase activity of b-lactamases. University of Huddersfield Repository (University of Huddersfield). 3 indexed citations
18.
Page, Michael I., et al.. (1998). Enantioselective biotransformations using rhodococci. Antonie van Leeuwenhoek. 74(1-3). 99–106. 19 indexed citations
19.
Page, Michael I.. (1991). The energetics of intramolecular reactions and enzyme catalysis. Philosophical Transactions of the Royal Society B Biological Sciences. 332(1263). 149–156. 20 indexed citations
20.
Page, Michael I.. (1984). New Comprehensive Biochemistry. Elsevier eBooks. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026